PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
13-Nov-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of E2open Parent Holdings, Inc. (ETWO) on Behalf of Investors Businesswire
13-Nov-2023 Q2 Announces New Executive Appointments Businesswire
13-Nov-2023 MedinCell Applauds Teva and Royalty Pharma Collaboration to Further Accelerate Olanzapine LAI Program (Codename: mdc-TJK or TEV-‘749) Businesswire
13-Nov-2023 MedinCell salue la collaboration entre Teva et Royalty Pharma visant à accélérer le développement du programme olanzapine LAI (nom de code : mdc-TJK ou TEV-‘749) Businesswire
13-Nov-2023 Model N Management to Present at the RBC Capital Markets Global Technology, Internet, Media, Telecommunications Conference Businesswire
13-Nov-2023 Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology Businesswire
13-Nov-2023 Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology Businesswire
13-Nov-2023 Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3 Businesswire
13-Nov-2023 Thermo Fisher Scientific Opens Customer Experience Center for Battery Manufacturing in Seoul Businesswire
13-Nov-2023 Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next‑Generation Lithium Therapeutic Drug Candidate AL001 Businesswire
13-Nov-2023 Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023 Businesswire
13-Nov-2023 Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program Businesswire
13-Nov-2023 Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update Businesswire
13-Nov-2023 Ankyra Therapeutics Announces Clinical Trial Supply Agreement with Regeneron to Evaluate ANK-101 in Combination with Libtayo® (cemiplimab) in Patients with Cutaneous Squamous Cell Carcinoma Businesswire
13-Nov-2023 Syngenta Group Announces Mary-Dell Chilton Awarded National Medal of Technology and Innovation Businesswire
13-Nov-2023 NEUPATH HEALTH ANNOUNCES SUCCESSFUL CLOSING OF UPDATED CREDIT FACILITY Businesswire
13-Nov-2023 Precision BioSciences Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD’s The Liver Meeting 2023 Businesswire
13-Nov-2023 Enanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Full Year Ended September 30, 2023 Businesswire
13-Nov-2023 Antibe Reports Q2 2024 Interim Financial and Operating Results Businesswire
13-Nov-2023 Incendia Therapeutics Appoints Wendye Robbins, M.D., as Chief Executive Officer and Doses First Patient in Phase 1b Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor Businesswire